Destino Medical Diagnostics P C is categorized under Health Services in Farmingdale, NY and active since 2012.
Destino Medical Diagnostics P C was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Salvatore Trazzera at the company’s single location by writing to 202 Fallwood Parkway, Farmingdale, New York NY 11735 or by phoning (631) 834-9380. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Destino Medical Diagnostics P C |
| Contact Person: | Salvatore Trazzera |
| Address: | 202 Fallwood Parkway, Farmingdale, New York 11735 |
| Phone Number: | (631) 834-9380 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Destino Medical Diagnostics P C was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Salvatore Trazzera for inquiries that concern Destino Medical Diagnostics P C by calling the company number (631) 834-9380, as your correspondence is most welcome. Additionally, the physical location of the single location of Destino Medical Diagnostics P C can be found at the coordinates 40.720465,-73.457713 as well as the street address 202 Fallwood Parkway in Farmingdale, New York 11735.
For its online presence, you may visit Destino Medical Diagnostics P C’s website at and engage with its social media outlets through on Twitter and on Facebook.